Invention Grant
- Patent Title: CD27L antigen binding proteins
- Patent Title (中): CD27L抗原结合蛋白
-
Application No.: US14618945Application Date: 2015-02-10
-
Publication No.: US09574008B2Publication Date: 2017-02-21
- Inventor: John M. Delaney , William C. Fanslow, III , Chadwick T. King
- Applicant: AMGEN INC.
- Applicant Address: US CA Thousand Oaks
- Assignee: AMGEN INC.
- Current Assignee: AMGEN INC.
- Current Assignee Address: US CA Thousand Oaks
- Agency: Marshall, Gerstein & Borun LLP
- Main IPC: A61K39/395
- IPC: A61K39/395 ; C07K16/30 ; C07K16/28 ; A61K47/48 ; A61K31/5365 ; A61K39/00
Abstract:
The present invention relates to CD27L antigen binding proteins, such an antibodies, polynucleotides encoding said CD27l antigen binding proteins, antibody drug conjugate compositions, and methods for diagnosing and treating diseases associated with CD27L expression.
Public/Granted literature
- US20150218284A1 CD27L ANTIGEN BINDING PROTEINS Public/Granted day:2015-08-06
Information query
